This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Interaction Between Levothyroxine and Probiotics in Hypothyroid Patients

Sponsored by Azienda USL Modena

About this trial

Last updated 8 years ago

Study ID

Levothyroxine and Probiotics

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 65 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 9 years ago

What is this trial about?

A prospective, randomized, single-blind, controlled, investigator-started clinical trial was carried out. Patients with primary hypothyroidism were randomly assigned to the study (VSL#3®+ LT4) and the control group (LT4). A two months treatment phase was followed by two months of follow-up. Clinical examination, blood tests for thyroid function and for peripheral tissue markers of thyroid hormones effect were performed monthly for 4 months. LT4 dose adjustments were performed during the study when necessary.

What are the participation requirements?

Yes

Inclusion Criteria

- primary hypothyroidism on LT4 replacement therapy

- TSH, fT3 and fT4 in the normal range

- stable LT4 dosage during the previous six months before enrolment

- Caucasian ethnicity

No

Exclusion Criteria

- total thyroidectomy for thyroid carcinoma

- high fiber diet

- intestinal malabsorption (e.g. bariatric surgery, inflammatory bowel diseases, coeliac disease)

- ongoing therapies interfering with LT4 absorption and/or metabolism (i.e. aluminium-containing antacids, sucralfate, proton pump inhibitors, calcium carbonate, raloxifene, bile acids sequestrants and ferrous sulfate)

- antibiotics treatment in the previous six months before enrolment